ReportsWeb- Rheumatoid Arthritis - Global Drug Forecast and Ma | Page 2

Reasons to buy The report will enable you to - - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the RA market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global RA market in the future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter- strategies to gain a competitive advantage. - Track drug sales in the eight major RA markets from 2015-2025. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. Companies Mentioned: AbbVie Pfizer Amgen Johnson & Johnson Eli Lilly Bristol-Myers Squibb UCB Roche GlaxoSmithKline Sanofi AstraZeneca- MedImmune Astellas Daiichi Sankyo Samsung Bioepis Sandoz Inquire for Report at http://www.reportsweb.com/inquiry&RW0001787456/buying Contact Us: Call: [phone] Email: [email protected]